Perceptive Advisors
Overview
Perceptive Advisors is an investment firm that focuses on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to promising technologies in healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Distalmotion | Oct 2026 | Debt | Co-investor |
| Superluminal Medicines | Sep 2026 | Series B | Co-investor |
| Entera Bio Ltd. | Aug 2026 | Private Placement | Co-investor |
| Vaderis Therapeutics | Aug 2026 | Series B | Co-investor |
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Gianna Hoffman-Luca
Senior Principal, Venture (PXV Funds)
Kriti Lall
Public And Private Biotech Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Perceptive Advisors based?
Perceptive Advisors is headquartered in New York City, New York, United States.
When was Perceptive Advisors founded?
Perceptive Advisors was founded in 1999.
How many portfolio companies does Perceptive Advisors have?
Perceptive Advisors has 103 portfolio companies in Caplight's dataset.
What are some companies in Perceptive Advisors's portfolio?
Recent investments visible on Caplight include Distalmotion, Superluminal Medicines, Entera Bio Ltd., Vaderis Therapeutics, Crystalys Therapeutics.
What was Perceptive Advisors's most recent investment?
Perceptive Advisors's most recent investment on Caplight was in Distalmotion in 2026.
What sectors does Perceptive Advisors focus on?
Perceptive Advisors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Consumer & Commerce, Consumer & Commerce, Real Estate & PropTech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.
What company stages does Perceptive Advisors focus on?
Perceptive Advisors typically invests at the MultiStage stage.
What is Perceptive Advisors's AUM?
Perceptive Advisors's assets under management are estimated between $1.0B and $10.0B.